These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6351211)

  • 41. A placebo-controlled study of pyritinol ('Encephabol') in dementia.
    Cooper AJ; Magnus RV
    Pharmatherapeutica; 1980; 2(5):317-22. PubMed ID: 7001490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical evaluation of piroxicam in rheumatoid arthritis by double blind comparative multi-center studies].
    Ryumachi; 1980 Jun; 20(3):220-8. PubMed ID: 6998024
    [No Abstract]   [Full Text] [Related]  

  • 43. [Use of D-penicillamine for the treatment of rheumatoid arthritis and the study of various mechanisms of its action].
    Trofimova TM; Panasiuk AF; Avdeeva ZhI; Tarasenkova TA; Astakhova TA
    Ter Arkh; 1980; 52(6):110-3. PubMed ID: 7404375
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical trial of Encephabol ampules in neurological and neurosurgical coma].
    Anghel M; Tetraru C; Popa G; Bazon S; Vasiliu V
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(1):137-9. PubMed ID: 397581
    [No Abstract]   [Full Text] [Related]  

  • 45. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Chlorbutin, azathioprine, D-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis. Comparative analysis of their effect on the indices of disease activity and progression].
    Krel' AA; Kanevskaia MZ; Rashchupkina ZP; Bolotin EV; Chichasova NV
    Ter Arkh; 1982; 54(6):82-92. PubMed ID: 7112429
    [No Abstract]   [Full Text] [Related]  

  • 47. Rheumatoid arthritis: supplemental L-cysteine in penicillamine treatment--a controlled study.
    Hørslev-Petersen K; Beyer J; Boesen PD; Helin P
    J Rheumatol; 1985 Jun; 12(3):637-40. PubMed ID: 3900396
    [No Abstract]   [Full Text] [Related]  

  • 48. A double-blind, crossover, multicentre study of piroxicam and indomethacin in the treatment of rheumatoid arthritis.
    Finstad R
    Br J Clin Pract; 1981 Jan; 35(1):35-9. PubMed ID: 7020731
    [No Abstract]   [Full Text] [Related]  

  • 49. [Treatment of cerebral deficiency syndrome in latent heart insufficiency].
    Mayerhofer CH
    ZFA (Stuttgart); 1977 Mar; 53(8):453-6. PubMed ID: 324166
    [No Abstract]   [Full Text] [Related]  

  • 50. Effectiveness of levamisole in rheumatoid arthritis: Immune changes and long-term results.
    Feldmann JL; Mery C; Amor B; Kahan A; de Gery A; Delbarre F
    Scand J Rheumatol; 1981; 10(1):1-8. PubMed ID: 7013056
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical testing of Danaden retard in functional psychoses from the aspect of slight to medium severe transient syndrome].
    Engelmann G
    Med Welt; 1975 Jul; 26(29-30):1380-4. PubMed ID: 1100984
    [No Abstract]   [Full Text] [Related]  

  • 52. [Chlorbutin, azathioprine, d-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis patients. III. A comparative analysis of their effect on the morphological manifestations of synovitis based on puncture biopsy data].
    Shekhter AB; Krel' AA; Chichasova NV; Rashchupkina ZP
    Ter Arkh; 1984; 56(2):121-31. PubMed ID: 6710393
    [No Abstract]   [Full Text] [Related]  

  • 53. [Our experience in the treatment of rheumatoid arthritis with D-penicillamine].
    Wysocka K; Kiczak J; Hawrylak E
    Wiad Lek; 1980 Apr; 33(8):607-10. PubMed ID: 7405223
    [No Abstract]   [Full Text] [Related]  

  • 54. [Nephrotic syndrome during a treatment of rheumatoid polyarthritis with pyritinol].
    Raul P; Pourel J; Wiederkehr P; Kessler M; Duheille J; Foliguet B; Grignon M
    Therapie; 1982; 37(4):492-3. PubMed ID: 7135333
    [No Abstract]   [Full Text] [Related]  

  • 55. [Copper metabolism in rheumatoid arthritis and influence of D-penicillamine treatment].
    Crouzet J; Nafziger J; Guillien P; Camus JP; Lièvre JA
    Rev Rhum Mal Osteoartic; 1973; 40(7):485-9. PubMed ID: 4756424
    [No Abstract]   [Full Text] [Related]  

  • 56. The effect of D-penicillamine on plasma amino acids in rheumatoid arthritis.
    Partsch G; Tausch G; Neuwirth E; Neumüller J
    Z Rheumatol; 1983; 42(3):126-9. PubMed ID: 6880413
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of patients with rheumatoid arthritis with DMARD (disease modifying anti-rheumatic drugs)].
    Halberg P
    Ugeskr Laeger; 1984 Jul; 146(27):1995-2000. PubMed ID: 6440327
    [No Abstract]   [Full Text] [Related]  

  • 58. [Zinc levels in blood and urine of rheumatoid arthritis patients after four months treatment with D-penicillamine].
    Teherani DK; Altmann H; Tausch G; Eberl R
    Z Rheumatol; 1980; 39(11-12):395-400. PubMed ID: 7282103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of D-penicillamine on lymphocyte subsets: correlation with clinical response in rheumatoid arthritis.
    Singh RR; Malaviya AN; Malaviya R; Sharma M; Shandilya R; Taneja V; Khare SD; Beri D; Kumar A; Mehra NK
    J Assoc Physicians India; 1994 Mar; 42(3):201-4. PubMed ID: 7860508
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Penicillamine in rheumatoid arthritis.
    Lancet; 1973 Mar; 1(7802):549-50. PubMed ID: 4119980
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.